HPL

Healthcare Pharmaceuticals Limited

CURRENT NEWS

::Healthcare Pharmaceuticals Limited::

18 September, 2011
Healthcare pharmaceuticals Achieves "International Star Award For Quality, Geneva 2011

03 July, 2009
Bondrova�, the third generation nitrogen containing bisphosphonate is now launched to fight against osteoporosis

Healthcare Pharmaceuticals Ltd.

To face the unmet medical need of Bangladesh, Healthcare Pharmaceuticals Limited (HPL) starts its journey as the licensee of F. Hoffmann La-Roche, Basel, Switzerland. Coping up the growing challenges of the twenty first century, HPL since its beginning adopts the innovative science and market insight to produce responsive products for a changing world. Focusing absolutely on the patients� need, HPL comes up with medicines of different therapeutic groups.

HPL established a state-of-the-art manufacturing plant in Bangladesh that has been designed, built and validated by the world class consultants of HPL with active support of Roche technical experts. The plant complies to the zone concept of Good Manufacturing Practices.

Over the past years we are sustaining with envious growth rate and today we are stuffed with 800 employees of different ethnicity, religion, sex with skilled people. We provide the channel of distributing our products to the end corners of our country through 13 depots. And now HPL wins the trust of millions of its customers.

Products

Health Alert

Vaccinate yourself against Cholera and Diarrhoea

Diarrhoea disease is a leading health problem in the developed countries. It has been estimated that 3-5 billion episodes of diarrhoea, resulting in approximately 4 million deaths, occur annually in developing countries. About half of these cases of diarrhoea are caused by bacteria. Cholera, resulting from Vibrio cholerae bacteria, is the most severe...

More...

| | | | | |